Syntec Optics (OPTX) Registration filing summary
Event summary combining transcript, slides, and related documents.
Registration filing summary
27 Apr, 2026Company overview and business model
Vertically integrated manufacturer of precision optics and photonics solutions for defense, bio-medical, communications, and consumer markets.
Offers design, manufacturing, and assembly of optical components and systems, leveraging nanomachining and advanced molding techniques.
Focuses on mission-critical applications such as night vision, diagnostics, satellite communications, AR/XR, and sensing technologies.
Competitive strengths include vertical integration, advanced technology expertise, diverse end-market exposure, and operational excellence.
Growth strategy centers on organic expansion, operational improvement, and selective strategic acquisitions.
Financial performance and metrics
Net sales for 2025 were $28.1 million, a 1.3% decrease from 2024, with gross profit rising 15% to $6.5 million.
Net loss improved to $1.8 million in 2025 from $2.5 million in 2024.
Adjusted EBITDA for 2025 was $3.0 million, up from $2.2 million in 2024.
Cash at year-end 2025 was $0.36 million, with $6.8 million outstanding under a $7.5 million revolving credit facility.
Three customers accounted for 48% of 2025 revenue; revenue mix includes defense, medical, consumer, and communications.
Use of proceeds and capital allocation
Estimated net proceeds of $18.6 million (up to $21.4 million if underwriter's option is exercised).
Proceeds intended for acquisitions or investments in complementary businesses, technologies, or assets.
Additional uses include working capital, capital expenditures, and potential repayment of indebtedness.
Management retains broad discretion over allocation of proceeds.
Latest events from Syntec Optics
- Margin expansion and cost controls boosted adjusted EBITDA, with 2026 growth expected in defense and AI optics.OPTX
Q4 20253 Apr 2026 - Strong H1 2025 profit growth and margin expansion driven by defense, biomedical, and communications.OPTX
Q2 202513 Feb 2026 - Gross margin rose to 29% in H1 2025 as sales and adjusted EBITDA improved year-over-year.OPTX
Q4 202413 Feb 2026 - Q1 2025 net income turned positive on 13% sales growth and improved margins.OPTX
Q1 202513 Feb 2026 - Q3 2025 revenue rose sequentially but margins fell; liquidity improved and Q4 outlook is positive.OPTX
Q3 202512 Feb 2026 - Q2 sales up 12% sequentially, product growth strong, and Q3 outlook robust.OPTX
Q2 20242 Feb 2026 - Q3 sales up 19% year-over-year, but higher costs led to a net loss; Q4 outlook is positive.OPTX
Q3 202413 Jan 2026 - Virtual meeting to vote on directors, auditor, RSUs, and governance amendments; board recommends approval.OPTX
Proxy Filing8 Dec 2025 - Shareholders will vote on director elections, auditor ratification, and RSU grants at the virtual annual meeting.OPTX
Proxy Filing2 Dec 2025